These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 27022702)
1. Design of Catalytic Peptides and Proteins Through Rational and Combinatorial Approaches. Maeda Y; Makhlynets OV; Matsui H; Korendovych IV Annu Rev Biomed Eng; 2016 Jul; 18():311-28. PubMed ID: 27022702 [TBL] [Abstract][Full Text] [Related]
2. Rational and "irrational" design of proteins and their use in biotechnology. Nixon AE; Firestine SM IUBMB Life; 2000 Mar; 49(3):181-7. PubMed ID: 10868908 [TBL] [Abstract][Full Text] [Related]
3. Combinatorial libraries of biocatalysts: application and screening. Cipolla L Comb Chem High Throughput Screen; 2004 Mar; 7(2):101-14. PubMed ID: 15032658 [TBL] [Abstract][Full Text] [Related]
12. Molecular descriptors in chemoinformatics, computational combinatorial chemistry, and virtual screening. Xue L; Bajorath J Comb Chem High Throughput Screen; 2000 Oct; 3(5):363-72. PubMed ID: 11032954 [TBL] [Abstract][Full Text] [Related]
13. Intelligent design in combinatorial chemistry: use of designed peptide libraries to explore secondary and tertiary structures in peptides and proteins. Cowell SM; Gu X; Vagner J; Hruby VJ Methods Enzymol; 2003; 369():288-97. PubMed ID: 14722960 [No Abstract] [Full Text] [Related]
14. Phage display of functional human TNF-alpha converting enzyme catalytic domain: a rapid method for the production of stabilized proteolytic proteins for assay development and high-throughput screening. Chen Y; Diener K; Patel IR; Kawooya JK; Martin GA; Yamdagni P; Zhang X; Sandrasalphaa A; Sahasrabudhe S; Busch SJ J Biomol Screen; 2002 Oct; 7(5):433-40. PubMed ID: 14599359 [TBL] [Abstract][Full Text] [Related]
15. Recent advances in the discovery of organometallic catalysts using high-throughput screening assays. Stambuli JP; Hartwig JF Curr Opin Chem Biol; 2003 Jun; 7(3):420-6. PubMed ID: 12826131 [TBL] [Abstract][Full Text] [Related]
16. Non-ribosomal peptide synthetases as technological platforms for the synthesis of highly modified peptide bioeffectors--Cyclosporin synthetase as a complex example. Velkov T; Lawen A Biotechnol Annu Rev; 2003; 9():151-97. PubMed ID: 14650927 [TBL] [Abstract][Full Text] [Related]
17. Recent advances in liquid-phase combinatorial chemistry. Sun CM Comb Chem High Throughput Screen; 1999 Dec; 2(6):299-318. PubMed ID: 10644856 [TBL] [Abstract][Full Text] [Related]